Assessing Avantor (AVTR) Valuation After Recent Share Price Weakness And Perceived Undervaluation

Simply Wall St.02-28

AdvertisementAvantor stock moves after recent performance shift Avantor (AVTR) has come into focus after a recent stretch of weaker share performance, with the stock showing negative returns over the ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2614606748?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","is_english":true,"pubTime":"2026-02-28 05:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2614606748","market":"sg","top_or_hot":-1,"title":"Assessing Avantor (AVTR) Valuation After Recent Share Price Weakness And Perceived Undervaluation","media":"Simply Wall St.","content":"<div>\n<p>AdvertisementAvantor stock moves after recent performance shift Avantor (AVTR) has come into focus after a recent stretch of weaker share performance, with the stock showing negative returns over the ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-avtr/avantor/news/assessing-avantor-avtr-valuation-after-recent-share-price-we\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Assessing Avantor (AVTR) Valuation After Recent Share Price Weakness And Perceived Undervaluation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAssessing Avantor (AVTR) Valuation After Recent Share Price Weakness And Perceived Undervaluation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-28 05:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-avtr/avantor/news/assessing-avantor-avtr-valuation-after-recent-share-price-we><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AdvertisementAvantor stock moves after recent performance shift Avantor (AVTR) has come into focus after a recent stretch of weaker share performance, with the stock showing negative returns over the ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-avtr/avantor/news/assessing-avantor-avtr-valuation-after-recent-share-price-we\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AVTR","symbol_name":"Avantor, Inc.","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-avtr/avantor/news/assessing-avantor-avtr-valuation-after-recent-share-price-we","article_id":"2614606748","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-avtr/avantor/news/assessing-avantor-avtr-valuation-after-recent-share-price-we","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2614606748","pubTimestamp":1772227550,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Avantor stock moves after recent performance shift\nAvantor (AVTR) has come into focus after a recent stretch of weaker share performance, with the stock showing negative returns over the past week, month and past 3 months, as well as over the past year.\nSee our latest analysis for Avantor.\nAt a share price of US$9.01, Avantor’s recent momentum has been weak, with a 30 day share price return of 22.66% and a 1 year total shareholder return of 45.36% pointing to sustained pressure on the...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"AVTR":"Avantor, Inc.","BK4121":"生命科学工具和服务"},"translate_title":"在近期股价疲软和被认为低估后评估Avantor(AVTR)的估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AVTR":1.5},"content_text":"AdvertisementAvantor stock moves after recent performance shift Avantor (AVTR) has come into focus after a recent stretch of weaker share performance, with the stock showing negative returns over the past week, month and past 3 months, as well as over the past year. See our latest analysis for Avantor. At a share price of US$9.01, Avantor’s recent momentum has been weak, with a 30 day share price return of 22.66% and a 1 year total shareholder return of 45.36% pointing to sustained pressure on the stock. If this recent weakness has you looking wider, it could be worth scanning other parts of the market, including our screener of 29 healthcare AI stocks as potential alternatives to research next. With Avantor trading at US$9.01 and indicators such as an intrinsic discount of 44.83% and a 21% discount to the average analyst price target, is this recent weakness a potential entry point, or is the market already pricing in future growth? Most Popular Narrative: 30.9% Undervalued With Avantor last closing at $9.01 against a narrative fair value of $13.04, the widely followed view points to a sizable valuation gap that rests on specific business shifts in services, costs and higher value products.  The continued acceleration of biologics, gene therapies, and personalized medicine creates an increasing need for specialized and single-use solutions, an area where Avantor is investing in market-leading platforms and expanding innovation, positioning the company to benefit from secular end-market growth and product mix shift toward higher-margin segments, supporting margin and earnings growth.  Read the complete narrative. Curious what revenue pace, margin path and future earnings multiple sit behind that fair value gap? The narrative leans on specific growth, profitability and valuation assumptions that paint a very different picture to the current share price. Result: Fair Value of $13.04 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, this hinges on execution, as pressure from aggressive pricing to win contracts and ongoing margin strain in bioprocessing are both capable of undermining that upside story. Find out about the key risks to this Avantor narrative. Next Steps With sentiment clearly mixed, and both risks and rewards in play, it makes sense to look at the data yourself and move quickly to shape your own view, starting with 3 key rewards and 1 important warning sign. Looking for more investment ideas? If Avantor has caught your attention, do not stop here. Use this as a prompt to widen your watchlist and compare opportunities side by side with fresh ideas.  Start with quality by scanning solid balance sheet and fundamentals stocks screener (41 results), which can help anchor your portfolio with companies backed by robust finances. Hunt for value by reviewing 54 high quality undervalued stocks, which our tools highlight as trading below their assessed worth based on current fundamentals. Spot potential early movers by checking our screener containing 24 high quality undiscovered gems before they sit firmly on everyone else's radar.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2614606748","isCrawlerRequest":true}